A Tale of Two Markets: Bridging the Gap Between Public and Private Life Sciences Company Valuations

Houlihan Lokey is pleased to present a white paper discussing bridging the gap between public and private life sciences company valuations. In this paper, we will:

• Explore the ever-evolving landscape of investments in the life sciences sector.
• Review key trends expected to impact the sector.
• Discuss methodologies and unique considerations for the valuation of biotech
  companies.
• Discuss how Houlihan Lokey helps its fund clients navigate private market valuations amid the public market volatility.